Investors eyeing a purchase of Sarepta Therapeutics Inc (NASD: SRPT) shares, but tentative about paying the going market price of $34.74/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $23 strike, which has a bid at the time of this writing of $4.00. Collecting that bid as the premium represents a 17.4% return against the $23 commitment, or a 12.5% annualized rate of ...
Investors eyeing a purchase of Sarepta Therapeutics Inc (NASD: SRPT) shares, but tentative about paying the going market price of $34.74/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $23 strike, which has a bid at the time of this writing of $4.00. Collecting that bid as the premium represents a 17.4% return against the $23 commitment, or a 12.5% annualized rate of ...
Share this Article
Comment on this Article
Recommended
Please to comment